WallStreetZenWallStreetZen

NASDAQ: MRNA
Moderna Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MRNA

Based on 11 analysts offering 12 month price targets for Moderna Inc.
Min Forecast
$93.00-39.81%
Avg Forecast
$196.55+27.2%
Max Forecast
$296.00+91.56%

Should I buy or sell MRNA stock?

Based on 11 analysts offering ratings for Moderna Inc.
Buy
Strong Buy
5 analysts 45.45%
Buy
2 analysts 18.18%
Hold
3 analysts 27.27%
Sell
1 analysts 9.09%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MRNA stock forecasts and price targets.

MRNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
TD Cowen
Bottom 6%
6
BuyUpgrades$180.00+16.49%2023-03-13
RBC Capital
Bottom 2%
2
BuyInitiates Coverage On$200.00+29.43%2023-03-02
Deutsche Bank
Top 27%
74
Strong BuyMaintains$200.00+29.43%2023-02-28
SVB Leerink
Bottom 1%
1
SellDowngrades$93.00-39.81%2023-02-24
JP Morgan
Top 10%
91
HoldMaintains$138.00-10.69%2023-02-08
Morgan Stanley
Bottom 4%
4
HoldMaintains$205.00+32.67%2023-01-24
Chardan Capital
Top 19%
82
HoldMaintains$208.00+34.61%2023-01-18
Piper Sandler
Bottom 8%
8
Strong BuyMaintains$217.00+40.43%2022-12-20Find out why
Jefferies
Top 12%
89
Strong BuyUpgrades$275.00+77.97%2022-12-19Find out why
Goldman Sachs
Top 10%
91
Strong BuyMaintains$296.00+91.56%2022-10-13

1 of 2

Forecast return on equity

Is MRNA forecast to generate an efficient return?
Company
N/A
Industry
-0.1%
Market
28.88%

Forecast return on assets

Is MRNA forecast to generate an efficient return on assets?
Company
N/A
Industry
0.01%

MRNA earnings per share forecast

What is MRNA's earnings per share in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$7.90-62.84%
Avg 2 year Forecast
$2.81-86.78%
Avg 3 year Forecast
$10.51-50.56%
MRNA's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

MRNA revenue forecast

What is MRNA's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$10.8B-43.92%
Avg 2 year Forecast
$7.1B-62.93%
Avg 3 year Forecast
$15.2B-21.28%
MRNA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MRNA earnings growth forecast

How is MRNA forecast to perform vs Biotechnology companies and vs the US market?
Company
-36.43%
Industry
10.24%
Market
19.48%
MRNA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MRNA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MRNA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MRNA revenue growth forecast

How is MRNA forecast to perform vs Biotechnology companies and vs the US market?
Company
-17.95%
Industry
40.95%
Market
8.76%
MRNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MRNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MRNA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MRNA$154.52$196.55+27.20%Buy
VRTX$298.95$325.36+8.83%Buy
SGEN$200.41$188.88-5.76%Buy
REGN$759.25$830.00+9.32%Buy
BNTX$132.08$217.63+64.77%Buy
View Top Biotech Stocks

Moderna Stock Forecast FAQ

Is Moderna Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: MRNA) stock is to Buy MRNA stock.

Out of 11 analysts, 5 (45.45%) are recommending MRNA as a Strong Buy, 2 (18.18%) are recommending MRNA as a Buy, 3 (27.27%) are recommending MRNA as a Hold, 1 (9.09%) are recommending MRNA as a Sell, and 0 (0%) are recommending MRNA as a Strong Sell.

If you're new to stock investing, here's how to buy Moderna stock.

What is MRNA's earnings growth forecast for 2023-2025?

(NASDAQ: MRNA) Moderna's forecast annual earnings growth rate of -36.43% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.24%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.48%.

Moderna's earnings in 2023 is $8,362,000,000.On average, 10 Wall Street analysts forecast MRNA's earnings for 2023 to be $3,052,082,793, with the lowest MRNA earnings forecast at -$1,634,216,483, and the highest MRNA earnings forecast at $5,555,563,362. On average, 6 Wall Street analysts forecast MRNA's earnings for 2024 to be $1,085,614,259, with the lowest MRNA earnings forecast at -$2,901,410,351, and the highest MRNA earnings forecast at $2,781,645,077.

In 2025, MRNA is forecast to generate $4,060,429,133 in earnings, with the lowest earnings forecast at -$150,672,442 and the highest earnings forecast at $8,267,667,312.

What is MRNA's revenue growth forecast for 2023-2025?

(NASDAQ: MRNA) Moderna's forecast annual revenue growth rate of -17.95% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 40.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.76%.

Moderna's revenue in 2023 is $19,263,000,000.On average, 8 Wall Street analysts forecast MRNA's revenue for 2023 to be $4,173,584,136,627, with the lowest MRNA revenue forecast at $1,540,606,398,994, and the highest MRNA revenue forecast at $7,106,894,547,843. On average, 6 Wall Street analysts forecast MRNA's revenue for 2024 to be $2,758,721,230,650, with the lowest MRNA revenue forecast at $1,708,702,756,343, and the highest MRNA revenue forecast at $3,524,255,454,199.

In 2025, MRNA is forecast to generate $5,858,067,263,822 in revenue, with the lowest revenue forecast at $2,313,053,783,237 and the highest revenue forecast at $9,403,080,744,407.

What is MRNA's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: MRNA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.01%.

What is MRNA's Price Target?

According to 11 Wall Street analysts that have issued a 1 year MRNA price target, the average MRNA price target is $196.55, with the highest MRNA stock price forecast at $296.00 and the lowest MRNA stock price forecast at $93.00.

On average, Wall Street analysts predict that Moderna's share price could reach $196.55 by Mar 13, 2024. The average Moderna stock price prediction forecasts a potential upside of 27.2% from the current MRNA share price of $154.52.

What is MRNA's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: MRNA) Moderna's current Earnings Per Share (EPS) is $21.26. On average, analysts forecast that MRNA's EPS will be $7.90 for 2023, with the lowest EPS forecast at -$4.23, and the highest EPS forecast at $14.38. On average, analysts forecast that MRNA's EPS will be $2.81 for 2024, with the lowest EPS forecast at -$7.51, and the highest EPS forecast at $7.20. In 2025, MRNA's EPS is forecast to hit $10.51 (min: -$0.39, max: $21.40).

What is MRNA's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: MRNA) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.